$MOTS
Motus GI Holdings Inc Stock $mots

$mots Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223010263 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$56.00K	$109.0K	$592.0K
YoY Change	180.0%	10.1%	51.41%
Cost Of Revenue	$9.000K	$471.0K	$198.0K
YoY Change	-94.83%	923.91%	9.39%
Gross Profit	$47.00K	-$362.0K	$394.0K
YoY Change	-130.52%	-783.02%	87.62%
Gross Profit Margin	83.93%	-332.11%	66.55%
Selling, General & Admin	$2.787M	$2.315M	$12.04M
YoY Change	-10.01%	-24.1%	-2.54%
% of Gross Profit	5929.79%		3054.82%
Research & Development	$1.454M	$1.350M	$5.611M
YoY Change	14.04%	3.77%	5.06%
% of Gross Profit	3093.62%		1424.11%
Depreciation & Amortization	$117.0K	$129.0K	$510.0K
YoY Change	-5.65%	6.61%	16.17%
% of Gross Profit	248.94%		129.44%
Operating Expenses	$4.241M	$3.665M	$17.65M
YoY Change	-3.0%	-15.77%	-0.25%
Operating Profit	-$4.359M	-$4.027M	-$17.85M
YoY Change	-3.69%	-6.31%	2.12%
Interest Expense	$308.0K	$345.0K	$1.331M
YoY Change	-208.07%	-231.18%	-251.77%
% of Operating Profit
Other Income/Expense, Net		$0.00	$0.00
YoY Change			-100.0%
Pretax Income	-$4.386M	-$3.682M	-$18.60M
YoY Change	-8.83%	-23.58%	-2.29%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$4.400M	-$3.682M	-$18.60M
YoY Change	-8.54%	-23.58%	-2.27%
Net Earnings / Revenue	-7857.14%	-3377.98%	-3141.89%
Basic Earnings Per Share	-$0.92		-$86.15
Diluted Earnings Per Share	-$0.92	-$0.79	-$5.74
COMMON SHARES
Basic Shares Outstanding	4.779M shares	4.656M shares
Diluted Shares Outstanding	317.5K shares		215.9K shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.648M	$14.04M	$14.04M
YoY Change	-57.48%	-37.77%	-37.77%
Cash & Equivalents	$8.600M	$14.00M	$14.04M
Short-Term Investments
Other Short-Term Assets	$1.093M	$781.0K	$781.0K
YoY Change	-18.86%	-1.51%	-1.51%
Inventory	$798.0K	$999.0K	$488.0K
Prepaid Expenses
Receivables	$52.00K	$59.00K	$59.00K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$10.26M	$15.37M	$15.37M
YoY Change	-54.22%	-35.85%	-35.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.237M	$1.325M	$1.753M
YoY Change	-38.43%	-7.21%	-17.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$13.00K	$13.00K	$524.0K
YoY Change	0.0%	0.0%	3930.77%
Total Long-Term Assets	$1.974M	$2.277M	$2.277M
YoY Change	-2.37%	7.0%	7.0%
TOTAL ASSETS
Total Short-Term Assets	$10.26M	$15.37M	$15.37M
Total Long-Term Assets	$1.974M	$2.277M	$2.277M
Total Assets	$12.23M	$17.65M	$17.65M
YoY Change	-49.92%	-32.36%	-32.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.472M	$1.969M	$1.969M
YoY Change	-26.1%	-23.8%	-23.8%
Accrued Expenses	$248.0K	$245.0K	$245.0K
YoY Change	-16.22%	-20.2%	-20.2%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.611M	$2.532M	$2.532M
YoY Change	141.09%	487.47%
Total Short-Term Liabilities	$4.378M	$4.799M	$4.799M
YoY Change	29.56%	44.03%	65.43%
LONG-TERM LIABILITIES
Long-Term Debt	$3.904M	$4.589M	$8.481M
YoY Change	-62.32%	-35.56%	-25.51%
Other Long-Term Liabilities	$1.128M	$1.390M	$1.390M
YoY Change	-45.69%	-35.2%	-35.2%
Total Long-Term Liabilities	$3.904M	$4.589M	$9.871M
YoY Change	-68.61%	-35.56%	-27.05%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.378M	$4.799M	$4.799M
Total Long-Term Liabilities	$3.904M	$4.589M	$9.871M
Total Liabilities	$13.32M	$14.67M	$14.67M
YoY Change	-15.82%	-10.72%	-10.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$145.7M	-$141.4M
YoY Change		15.19%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.085M	$2.977M	$2.977M
YoY Change
Total Liabilities & Shareholders Equity	$12.23M	$17.65M	$17.65M
YoY Change	-49.92%	-32.36%	-32.36%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$4.400M	-$3.682M	-$18.60M
YoY Change	-8.54%	-23.58%	-2.27%
Depreciation, Depletion And Amortization	$117.0K	$129.0K	$510.0K
YoY Change	-5.65%	6.61%	16.17%
Cash From Operating Activities	-$4.800M	-$4.038M	-$17.47M
YoY Change	-8.5%	3.09%	21.11%
INVESTING ACTIVITIES
Capital Expenditures	$39.00K	$9.000K	$224.0K
YoY Change	-4000.0%	-120.0%	-147.66%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$39.00K	-$9.000K	-$224.0K
YoY Change	3800.0%	-80.0%	-52.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$10.25M
YoY Change			-26.03%
Debt Paid & Issued, Net			$703.0K
YoY Change			-87.76%
Cash From Financing Activities	-$553.0K	4.795M	$9.170M
YoY Change	-118.3%	66.9%	-44.88%
NET CHANGE
Cash From Operating Activities	-$4.800M	-4.038M	-$17.47M
Cash From Investing Activities	-$39.00K	-9.000K	-$224.0K
Cash From Financing Activities	-$553.0K	4.795M	$9.170M
Net Change In Cash	-$5.394M	748.0K	-$8.521M
YoY Change	142.43%	-168.69%	-588.59%
FREE CASH FLOW
Cash From Operating Activities	-$4.800M	-$4.038M	-$17.47M
Capital Expenditures	$39.00K	$9.000K	$224.0K
Free Cash Flow	-$4.839M	-$4.047M	-$17.69M
YoY Change	-7.74%	4.52%	26.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001686850
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2022	mots	Deemed Dividends From Warrant Issuance DeemedDividendsFromWarrantIssuance		usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2021	mots	Fractional Shares Paid In Cash Pursuant To Reverse Stock Split FractionalSharesPaidInCashPursuantToReverseStockSplit		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2022	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
CY2022	mots	Common Stock Issued To Settle Accrued Expenses For Board Of Directors Compensation CommonStockIssuedToSettleAccruedExpensesForBoardOfDirectorsCompensation		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	mots	Accrued End Of Loan Payment Recorded As Debt Discount AccruedEndOfLoanPaymentRecordedAsDebtDiscount		usd
CY2022	mots	Prepayment Of Lease Obligation PrepaymentOfLeaseObligation		usd
CY2022	us-gaap	Operating Lease Income Comprehensive Income Extensible List OperatingLeaseIncomeComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2022#Revenues
CY2021	us-gaap	Operating Lease Income Comprehensive Income Extensible List OperatingLeaseIncomeComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2022#Revenues
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess		usd
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent		usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021Q4	mots	Deferred Tax Liabilities Accelerated Research And Development Expense DeferredTaxLiabilitiesAcceleratedResearchAndDevelopmentExpense		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-38389
CY2022	dei	Entity Registrant Name EntityRegistrantName	Motus GI Holdings, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-4042793
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1301 East Broward Boulevard
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	3rd Floor
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Ft. Lauderdale
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33301
CY2022	dei	City Area Code CityAreaCode	(954)
CY2022	dei	Local Phone Number LocalPhoneNumber	541-8000
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2022	dei	Trading Symbol TradingSymbol	MOTS
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	14600000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4778873	shares
CY2022	dei	Auditor Firm AuditorFirmId	274
CY2022	dei	Auditor Name AuditorName	EISNERAMPER LLP
CY2022	dei	Auditor Location AuditorLocation	Philadelphia, Pennsylvania
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14042000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22563000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	59000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	109000	usd
CY2022Q4	mots	Inventory Current InventoryCurrent	488000	usd
CY2021Q4	mots	Inventory Current InventoryCurrent	496000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	781000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	793000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	15370000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	23961000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1325000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1428000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	511000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	428000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	687000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13000	usd
CY2022Q4	us-gaap	Assets Assets	17647000	usd
CY2021Q4	us-gaap	Assets Assets	26089000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1969000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2584000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	245000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	307000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	53000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	182000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	271000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2532000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	431000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4799000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3332000	usd
CY2022Q4	mots	Contingent Royalty Obligation ContingentRoyaltyObligation	1212000	usd
CY2021Q4	mots	Contingent Royalty Obligation ContingentRoyaltyObligation	1760000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	178000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	385000	usd
CY2022Q4	mots	Convertible Debt Unamortized Discount Noncurrent ConvertibleDebtUnamortizedDiscountNoncurrent	108000	usd
CY2021Q4	mots	Convertible Debt Unamortized Discount Noncurrent ConvertibleDebtUnamortizedDiscountNoncurrent	166000	usd
CY2022Q4	mots	Convertible Note Noncurrent ConvertibleNoteNoncurrent	3892000	usd
CY2021Q4	mots	Convertible Note Noncurrent ConvertibleNoteNoncurrent	3834000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	135000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	317000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4589000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7121000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	14670000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	16432000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	115000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	115000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4659769	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4659769	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2416021	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2416021	shares
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	144328000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	132411000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-141351000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-122754000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2977000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	9657000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17647000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26089000	usd
CY2022	us-gaap	Revenues Revenues	592000	usd
CY2021	us-gaap	Revenues Revenues	391000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	198000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	181000	usd
CY2022	mots	Costs Of Revenue Impairment Of Inventory CostsOfRevenueImpairmentOfInventory	598000	usd
CY2021	mots	Costs Of Revenue Impairment Of Inventory CostsOfRevenueImpairmentOfInventory	443000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5611000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5341000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4425000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3077000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7611000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9273000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	18443000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	18315000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-17851000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-17924000	usd
CY2022	mots	Loss On Changes In Fair Value Of Contingent Royalty Obligation LossOnChangesInFairValueOfContingentRoyaltyObligation	-548000	usd
CY2021	mots	Loss On Changes In Fair Value Of Contingent Royalty Obligation LossOnChangesInFairValueOfContingentRoyaltyObligation	143000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-237000	usd
CY2022	mots	Finance Income Expense Net FinanceIncomeExpenseNet	1252000	usd
CY2021	mots	Finance Income Expense Net FinanceIncomeExpenseNet	717000	usd
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	5000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-42000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-17000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-18597000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-19033000	usd
CY2021	mots	Deemed Dividends From Warrant Issuance DeemedDividendsFromWarrantIssuance	6145000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18597000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25178000	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.74
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-10.74
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	3237952	shares
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	2344759	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11290000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1826000	usd
CY2021	mots	Issuance Of Common Stock Upon Exercise Of Warrants IssuanceOfCommonStockUponExerciseOfWarrants	11593000	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	291000	usd
CY2021	mots	Stock Issued During Period Fractional Shares Settled In Cash Pursuant To Reverse Stock Split Value StockIssuedDuringPeriodFractionalSharesSettledInCashPursuantToReverseStockSplitValue	53	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	165	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3472000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-19033000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	9657000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	9657000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	368000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9884000	usd
CY2022	mots	Stock Issued During Period Fractional Shares Settled In Cash Pursuant To Reverse Stock Split Value StockIssuedDuringPeriodFractionalSharesSettledInCashPursuantToReverseStockSplitValue	-11	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	235000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1809000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-18597000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2977000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2977000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-18597000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-19033000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	510000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	439000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	330000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	95000	usd
CY2022	mots	Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation	548000	usd
CY2021	mots	Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation	-143000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1809000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3472000	usd
CY2022	mots	Issuance Of Common Stock For Board Of Directors Compensation IssuanceOfCommonStockForBoardOfDirectorsCompensation	235000	usd
CY2021	mots	Issuance Of Common Stock For Board Of Directors Compensation IssuanceOfCommonStockForBoardOfDirectorsCompensation	235000	usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	53000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-237000	usd
CY2022	mots	Impairment Of Inventory ImpairmentOfInventory	598000	usd
CY2021	mots	Impairment Of Inventory ImpairmentOfInventory	443000	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	46000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	327000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	262000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-50000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	74000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1302000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	274000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-12000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	413000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-650000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	303000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-330000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-260000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	43000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-50000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17467000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14422000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	224000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	470000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-224000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-470000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10252000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1900000	usd
CY2022	mots	Fractional Shares Paid In Cash Pursuant To Reverse Stock Split FractionalSharesPaidInCashPursuantToReverseStockSplit	11000	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	11959000	usd
CY2021	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	12000000	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	703000	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	8220000	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	563000	usd
CY2022	mots	Payments For Equity Financing Fees PaymentsForEquityFinancingFees	368000	usd
CY2021	mots	Payments For Equity Financing Fees PaymentsForEquityFinancingFees	440000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9170000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16636000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8521000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1744000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22563000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	20819000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14042000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22563000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	977000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	640000	usd
CY2021	mots	Common Stock Issued To Settle Accrued Expenses For Board Of Directors Compensation CommonStockIssuedToSettleAccruedExpensesForBoardOfDirectorsCompensation	56000	usd
CY2022	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	201000	usd
CY2021	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	140000	usd
CY2022	mots	Purchase Of Fixed Assets In Prepaid Expenses PurchaseOfFixedAssetsInPrepaidExpenses	4000	usd
CY2021	mots	Purchase Of Fixed Assets In Prepaid Expenses PurchaseOfFixedAssetsInPrepaidExpenses	75000	usd
CY2022	mots	Purchase Of Property And Equipment In Accounts Payable And Accrued Expenses PurchaseOfPropertyAndEquipmentInAccountsPayableAndAccruedExpenses	24000	usd
CY2021	mots	Purchase Of Property And Equipment In Accounts Payable And Accrued Expenses PurchaseOfPropertyAndEquipmentInAccountsPayableAndAccruedExpenses	4000	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	165000	usd
CY2021	mots	Accrued End Of Loan Payment Recorded As Debt Discount AccruedEndOfLoanPaymentRecordedAsDebtDiscount	140000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	66000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	184000	usd
CY2021	mots	Prepayment Of Lease Obligation PrepaymentOfLeaseObligation	17000	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_805_eus-gaap--NatureOfOperations_zuMoW7lMKl63" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – <span id="xdx_820_z5irFm0SEbIl">Description of Business</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motus GI Holdings, Inc. (the “Company”) was incorporated in Delaware, U.S.A. in September 2016. The Company and its subsidiaries, Motus GI Technologies, Ltd. and Motus GI, LLC, are collectively referred to as “Motus GI” or the “Company”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the “FDA”) to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (“GI”) endoscopy procedures. The Pure-Vu System has received a CE Mark in the EU for use in colonoscopy. The Pure-Vu System integrates with standard and slim colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Through irrigation and evacuation of debris, the Pure-Vu System is designed to provide better-quality exams. The Company received 510(k) clearance in February 2022 from the FDA for the Pure-Vu EVS System and has commenced initial commercialization of this product. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not expect to generate significant revenue from product sales until it further expands its commercialization efforts, which is subject to significant uncertainty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-18600000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14000000.0	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-141400000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zLCh00ujSol8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_z4H5ycMaeLac">Basis of presentation and use of estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and include the accounts of the Company and its wholly owned subsidiaries, Motus Ltd., an Israel corporation, which has operations in Tirat Carmel, Israel, and Motus Inc., a Delaware corporation, which has operations in the U.S. All inter-company accounts and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification, or ASC, and Accounting Standards Updates, or ASUs, of the Financial Accounting Standards Board (“FASB”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2022	us-gaap	Revenues Revenues	592000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	540000	usd
CY2022	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	52000	usd
CY2021	us-gaap	Revenues Revenues	391000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	303000	usd
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	88000	usd
CY2022	us-gaap	Payments For Commissions PaymentsForCommissions	96000	usd
CY2021	us-gaap	Payments For Commissions PaymentsForCommissions	35000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022	us-gaap	Servicing Liability At Fair Value Description Of Other Changes In Fair Value ServicingLiabilityAtFairValueDescriptionOfOtherChangesInFairValue	the Company recalculated the fair value of the liability by applying a +/- 2% change to the input variable in the discounted cash flow model; the discount rate. A 2% decrease in the discount rate would increase the liability by approximately $126 and a 2% increase in the discount rate would decrease the liability by approximately $112.
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	697000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	569000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	155000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	548000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	292000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	401000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	365000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	999000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	496000	usd
CY2022Q4	mots	Inventory Current InventoryCurrent	488000	usd
CY2021Q4	mots	Inventory Current InventoryCurrent	496000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	511000	usd
CY2022	mots	Cost Of Revenue Impairment Of Inventory CostOfRevenueImpairmentOfInventory	598000	usd
CY2021	mots	Cost Of Revenue Impairment Of Inventory CostOfRevenueImpairmentOfInventory	443000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3218000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2818000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1893000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1390000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1325000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1428000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	510000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	439000	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	46000	usd
CY2022	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	Certain operating leases include escalation clauses and some of which may include options to extend the leases for up to 3 years.
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	92000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	139000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	120000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	119000	usd
CY2022	us-gaap	Lease Cost LeaseCost	212000	usd
CY2021	us-gaap	Lease Cost LeaseCost	258000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	428000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	687000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	245000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	307000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	178000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	385000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	423000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	692000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M14D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y5M26D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0736	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0766	pure
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	212000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	258000	usd
CY2022	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	242000	usd
CY2021	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	189000	usd
CY2022	mots	Loss On Change In Fair Value Of Contingent Royalty Obligation LossOnChangeInFairValueOfContingentRoyaltyObligation	548000	usd
CY2021	mots	Loss On Change In Fair Value Of Contingent Royalty Obligation LossOnChangeInFairValueOfContingentRoyaltyObligation	143000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	266000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	176000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	7000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	449000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	26000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	423000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	342000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	324000	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	1001000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	330000	usd
CY2022	us-gaap	Interest Expense InterestExpense	1331000	usd
	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	1332000	usd
CY2022Q4	mots	London Interbank Offered Rate LondonInterbankOfferedRate	1426000	usd
CY2021Q4	mots	London Interbank Offered Rate LondonInterbankOfferedRate	1419000	usd
CY2022	mots	Royalties Percentage RoyaltiesPercentage	0.04	pure
CY2022	mots	Net Sales Percentage NetSalesPercentage	0.03	pure
CY2022	mots	Licensing Percentage LicensingPercentage	0.05	pure
CY2022	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	30000000	usd
CY2022	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	30000000	usd
CY2022Q4	mots	Contingent Royalty Obligation Non Current ContingentRoyaltyObligationNonCurrent	1212000	usd
CY2021Q4	mots	Contingent Royalty Obligation Non Current ContingentRoyaltyObligationNonCurrent	1760000	usd
CY2022	us-gaap	Severance Costs1 SeveranceCosts1	1408000	usd
CY2022	us-gaap	Manufacturing Costs ManufacturingCosts	41000	usd
CY2022	mots	License Fees LicenseFees	242000	usd
CY2021	mots	License Fees LicenseFees	189000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1809000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3472000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y9M18D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y9M18D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.9921	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.0624	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0210	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0077	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.62
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	26.4
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	26	shares
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	37400000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	27200000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	37400000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	27200000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	10200000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	14614000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	5281000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	18813000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	19354000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1735000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1732000	usd
CY2022Q4	mots	Deferred Tax Asset Deferred Expense Capitalized Research And Development Costs DeferredTaxAssetDeferredExpenseCapitalizedResearchAndDevelopmentCosts	2246000	usd
CY2021Q4	mots	Deferred Tax Asset Deferred Expense Capitalized Research And Development Costs DeferredTaxAssetDeferredExpenseCapitalizedResearchAndDevelopmentCosts	218000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	681000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	831000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	38089000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	27416000	usd
CY2022Q4	mots	Deferred Tax Liabilities Accelerated Research And Development Expense DeferredTaxLiabilitiesAcceleratedResearchAndDevelopmentExpense	548000	usd
CY2022Q4	mots	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	109000	usd
CY2021Q4	mots	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	158000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	34000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	14000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	691000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	172000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	37398000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	27244000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	37398000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	27244000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.066	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.020	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.008	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.009	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.027	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.019	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.107	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.025	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.150	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.245	pure
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	134100000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	119600000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	4900000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	8800000	usd
CY2021Q4	mots	Operating Loss Carryforwards Utilization Limitation OperatingLossCarryforwardsUtilizationLimitation	3700000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	26875000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	18420000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	25464000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	17009000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	81794000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	84148000	usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	134133000	usd
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	119577000	usd
CY2022	mots	Expire Date Description ExpireDateDescription	begin to expire after 2036 through 2042

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
mots-20221231_def.xml	Edgar Link	unprocessable
0001493152-23-010263-index-headers.html	Edgar Link	pending
0001493152-23-010263-index.html	Edgar Link	pending
0001493152-23-010263.txt	Edgar Link	pending
0001493152-23-010263-xbrl.zip	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
form10-k_002.jpg	Edgar Link	pending
form10-k_003.jpg	Edgar Link	pending
form10-k_004.jpg	Edgar Link	pending
form10-k_005.jpg	Edgar Link	pending
form10-k_006.jpg	Edgar Link	pending
form10-k_009.jpg	Edgar Link	pending
form10-k_010.jpg	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mots-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
mots-20221231_cal.xml	Edgar Link	unprocessable
mots-20221231_lab.xml	Edgar Link	unprocessable
mots-20221231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MOTS
Motus GI Holdings Inc Stock $mots

2023 Q1 Form 10-K Financial Statement

#000149315223010263 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOTS Motus GI Holdings Inc Stock $mots

2023 Q1 Form 10-K Financial Statement

#000149315223010263 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOTS
Motus GI Holdings Inc Stock $mots